EUVIMEDEUVIMED entdecken
Open Access

Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy

Laure Ponthier, Bénédicte Franck, Julie Autmizguine, Marc Labriffe, Philippe Ovetchkine, Pierre Marquet, Anders Åsberg, Jean-Baptiste Woillard iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00860-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Laure Ponthier und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Transplantation, INSERM U1248, Université de Limoges, Limoges, France. Hauptthemen laut MEDLINE: Ganciclovir, Valganciclovir, Machine Learning, Antiviral Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intravenous ganciclovir and oral valganciclovir display significant variability in ganciclovir pharmacokinetics, particularly in children. Therapeutic drug monitoring currently relies on the area under the concentration-time (AUC). Machine-learning (ML) algorithms represent an interesting alternative to Maximum-a-Posteriori Bayesian-estimators for AUC estimation. The goal of our study was to develop and validate an ML-based limited sampling strategy (LSS) approach to determine ganciclovir AUC 0–24 after administration of either intravenous ganciclovir or oral valganciclovir in children. Pharmacokinetic parameters from four published population pharmacokinetic models, in addition to the World Health Organization growth curve for children, were used in the mrgsolve R package to simulate 10,800 pharmacokinetic profiles of children. Different ML algorithms were trained to predict AUC 0–24 based on different combinations of two or three samples. Performances were evaluated in a simulated test set and in an external data set of real patients. The best estimation performances in the test set were obtained with the Xgboost algorithm using a 2 and 6 hours post dose LSS for oral valganciclovir (relative mean prediction error [rMPE] = 0.4% and relative root mean square error [rRMSE] = 5.7%) and 0 and 2 hours post dose LSS for intravenous ganciclovir (rMPE = 0.9% and rRMSE = 12.4%). In the external data set, the performance based on these two sample LSS was acceptable: rMPE = 0.2% and rRMSE = 16.5% for valganciclovir and rMPE = −9.7% and rRMSE = 17.2% for intravenous ganciclovir. The Xgboost algorithm developed resulted in a clinically relevant individual estimation using only two blood samples. This will improve the implementation of AUC-targeted ganciclovir therapeutic drug monitoring in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GanciclovirValganciclovirMachine LearningAntiviral AgentsDrug MonitoringArea Under CurveHumansChildChild, PreschoolBayes TheoremAlgorithmsAdministration, OralMaleFemaleCytomegalovirus InfectionsInfantAdministration, IntravenousAdolescent

Stichwörter der Autor:innen

Xgboostartificial intelligencechildrenganciclovirmachine learningpharmacokineticspharmacometricstransplantationvalganciclovir

Substanzen

GanciclovirValganciclovirAntiviral Agents

Autor:innen und Institutionen

  • Pharmacology and Transplantation, INSERM U1248, Université de Limoges, Limoges, France.
  • Department of Pediatrics, University Hospital of Limoges, Limoges, France.
  • Department of Clinical and Biological Pharmacology and Pharmacovigilance, Clinical Investigation Center CIC-P 1414, Rennes, France.
  • Department of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec, Canada.
  • Research Center, Center Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
  • Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.

ORCID-Profile: Jean-Baptiste Woillard

Zitieren

APA

Ponthier, L., Franck, B., Autmizguine, J., Labriffe, M., Ovetchkine, P., Marquet, P., Åsberg, A., & Woillard, J. B. (2024). Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00860-24

Vancouver

Ponthier L, Franck B, Autmizguine J, Labriffe M, Ovetchkine P, Marquet P, et al. Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00860-24

BibTeX
@article{Ponthier2024,
  author = {Ponthier, Laure and Franck, Bénédicte and Autmizguine, Julie and Labriffe, Marc and Ovetchkine, Philippe and Marquet, Pierre and Åsberg, Anders and Woillard, Jean-Baptiste},
  title = {Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00860-24}
}
Kostenlos starten →